
Conference Coverage
Latest News

Guiding Patients With Sickle Cell Disease Through the Transformative Era of Gene Therapy

Bridging Response Emerges as Key Predictor of Cilta-Cel Outcomes in CARTITUDE-4

Long-Term BENEFIT Data Affirm Isa-VRd as Standard of Care in Transplant-Ineligible NDMM

Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution

American Cancer Society Updates Cervical Cancer Screening Guidelines to Include Self-Collection for HPV Testing

Shorts










Podcasts
Videos
Continuing Medical Education
All News

Although highly efficacious, patient selection and adverse event management are crucial.

The Advisory Committee on Immunization Practices (ACIP) voted to recommend individual-based decision-making for parents when deciding when or if to give their child the birth dose of the hepatitis B virus vaccine.


Palbociclib Combination Is Safe, Efficacious in Patients With HER2-Positive Metastatic Breast Cancer
Discover how the combination of palbociclib, trastuzumab, and endocrine therapy enhances survival in HER2-positive advanced breast cancer patients.

Breyanzi becomes the first FDA-approved CAR-T therapy for relapsed marginal zone lymphoma, offering hope with impressive response rates and durable outcomes.

MRD and ctDNA testing could revolutionize monitoring and diagnosing precursor diseases of multiple myeloma.

The Emerging Practice Model Is Having a Moment in Popular Culture. What Is It and What Is the Role of Pharmacy?

Continuous glucose monitoring (CGM) via interstitial fluid, sweat, and saliva are less invasive than prior methods.

Emerging pharmacy trends will be highlighted at the American Society of Health-System Pharmacists (ASHP) Midyear 2025, including AI innovations, GLP-1 therapies, and evolving geriatric and neonatal care.

The FDA approves a new dose of Omlyclo, the first interchangeable biosimilar to Xolair, enhancing treatment options for allergic and inflammatory conditions.

Research reveals low-dose cannabinoids, like THC, may enhance serotonin levels and combat chronic inflammation in HIV patients, offering new treatment possibilities.

Researchers explore how immune history and innovative vaccine technologies enhance protection against flu, highlighting pharmacists' vital role in patient education.

Implementing a best practice advisory into physicians’ electronic health records improved lipid therapy initiation and diagnoses of hyperlipidemia and hypercholesterolemia.


Pirtobrutinib’s indication was expanded for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, allowing for treatment in earlier lines of therapy.

The supplemental new drug application (sNDA) was assigned a PDUFA target action date of July 26, 2026.

Pharmacists can help close the lung cancer screening gap by identifying high-risk tobacco users, increasing awareness, and connecting eligible patients to lifesaving early detection.

A new rapid test for pertussis enables quick diagnosis in as little as 15 minutes, addressing rising whooping cough cases.



The pneumococcal 13-valent conjugate vaccine (PCV13) was effective at preventing pneumococcal lower respiratory tract infection (LRTI) in older patients from Thailand.

A cohort study of over 6 million US veterans revealed a 76% increased risk of pancreatic cancer following chronic hepatitis C infection.

A 3-month resistance exercise program helped improve walking distance, grip strength, and other parameters of physical health in patients with long COVID.


































